LANDOS BIOPHARMA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.33 USD | +0.09% |
|
+1.68% | +510.11% |
| 04-02 | North American Morning Briefing : Stocks Seen -2- | DJ |
| 04-01 | HC Wainwright Downgrades Landos Biopharma to Neutral From Buy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LANDOS BIOPHARMA, INC. | Other Biotechnology & Medical Research | +0.09% | +1.68% | +510.11% | +670.00% | - | 69.74M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- LABP Stock
- Charts Landos Biopharma, Inc.
- Comparison Chart
